227 related articles for article (PubMed ID: 18726842)
1. Assessment of a biliary hamartoma with contrast-enhanced sonography using two different contrast agents.
Hohmann J; Loddenkemper C; Albrecht T
Ultraschall Med; 2009 Apr; 30(2):185-8. PubMed ID: 18726842
[TBL] [Abstract][Full Text] [Related]
2. Imaging diagnosis-cholangiocellular adenoma: contrast-enhanced ultrasonographic findings of a benign tumor mimicking malignant neoplasia in a dog.
Baron Toaldo M; Diana A; Bettini G; Di Donato P; Linta N; Cipone M
Vet Radiol Ultrasound; 2013; 54(1):71-4. PubMed ID: 23094700
[TBL] [Abstract][Full Text] [Related]
3. A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.
Ignee A; Piscaglia F; Ott M; Salvatore V; Dietrich CF
Scand J Gastroenterol; 2009; 44(5):633-6. PubMed ID: 19396663
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
[TBL] [Abstract][Full Text] [Related]
5. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.
Heide R; Strobel D; Bernatik T; Goertz RS
Ultraschall Med; 2010 Aug; 31(4):405-9. PubMed ID: 20652853
[TBL] [Abstract][Full Text] [Related]
6. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
12. Angiographic findings in multiple bile-duct hamartomas of the liver.
McLoughlin MJ; Phillips MJ
Radiology; 1975 Jul; 116(1):41-3. PubMed ID: 1138280
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
14. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma.
Li C; Wang W; Ding H; Huang B; Cao J; Mao F; Ji Z
J Clin Ultrasound; 2011 Oct; 39(8):447-53. PubMed ID: 21626512
[TBL] [Abstract][Full Text] [Related]
15. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
[TBL] [Abstract][Full Text] [Related]
16. The radiologic and pathologic spectrum of biliary hamartomas.
Lev-Toaff AS; Bach AM; Wechsler RJ; Hilpert PL; Gatalica Z; Rubin R
AJR Am J Roentgenol; 1995 Aug; 165(2):309-13. PubMed ID: 7618546
[TBL] [Abstract][Full Text] [Related]
17. Liver tumor characterization--review of the literature.
Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
[TBL] [Abstract][Full Text] [Related]
18. [Multiple bile duct hamartomas of the liver -- a rare differential diagnosis to liver metastasis].
Hettinger M; Klotz M; Bolay L; Weber P
Ultraschall Med; 2005 Apr; 26(2):150-3. PubMed ID: 15852180
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
20. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
von Herbay A; Haeussinger D; Gregor M; Vogt C
Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
